CAN WILSON'S DISEASE PATIENTS BE DECOPPERED?

This publication has 9 references indexed in Scilit:

• Studies on the uptake and subsequent tissue distribution of [35S]trithiomolybdate in rats: effects on metallothionein copper in liver, kidney, and
  Journal of Inorganic Biochemistry, 1988
• Studies of the changes in systemic copper metabolism and excretion produced by the intravenous administration of trithiomolybdate in sheep
  British Journal of Nutrition, 1988
• The uptake and intracellular distribution of [35S] trithiomolybdate in bovine liver in vivo
  Journal of Inorganic Biochemistry, 1987
• The Use of Trientine in Preventing the Effects of Interrupting Penicillamine Therapy in Wilson's Disease
  New England Journal of Medicine, 1987
• PENICILLAMINE MAY DETOXIFY COPPER IN WILSON'S DISEASE
  The Lancet, 1987
• Metallothionein
  Experimental Biology and Medicine, 1987
• Thiomolybdates: Mediators of molybdenum toxicity and enzyme inhibitors
  Toxicology, 1986
• Intravenous administration of thiomolybdate for the prevention and treatment of chronic copper poisoning in sheep
  British Journal of Nutrition, 1981
• Penicillamine, a new oral therapy for Wilson's disease
  The American Journal of Medicine, 1956